SEATTLE, WA--(Marketwired - October 29, 2014) - Corum Group, the leading global software M&A advisory firm, announced today the acquisition of its client OrthoView Holdings Limited by Materialise, a provider of 3D printing software and services based in Belgium. UK-based OrthoView is the world's leading provider of 2D digital pre-operative planning and templating solutions for orthopedic surgeons.

"This is an excellent match, and an exciting deal to have been a part of," said Corum Senior Vice President Jon Scott, who led the deal. "We're very pleased to have helped partner the market leader in orthopedic surgery software with a technological pioneer like Materialise, especially with them at the forefront of the cutting edge realm of 3D printing."

"We benefited from both Corum's depth and breadth during this process," said OrthoView co-founder and CEO John Chambers. "Their experience and knowledge of the technology industry made it possible for us to conduct a broad, global search for the right partner, and we're thrilled to have found the ideal match in Materialise."

OrthoView's X-ray based, pre-operative planning software is used in 2000 hospitals worldwide. The software imports a digital X-ray image from a Picture Archiving Communications System and positions the templates of suitable prostheses on the X-ray image at the correct scale. OrthoView currently serves more than 11,000 orthopedic surgeons in 60 countries globally, focusing primarily on joint replacements.

The transaction is Corum's fourth in the healthcare space in the last 18 months, and the company sees the robust activity in the sector continuing. "Healthcare is being transformed, and healthtech M&A is being driven, by dramatic regulatory, social and, in this case, technological change," said Corum Group Vice President and Director of Research Elon Gasper. "Each of these key trends is creating the needs and opportunities that drive M&A."

About Corum 
Corum Group is the global leader in merger and acquisition services, specializing in serving sellers of software and information technology companies worldwide. With offices globally, Corum has completed over US $7 billion in software M&A transactions over the last 30 years, spanning six continents. Corum also educates the industry with its popular conferences and publishes the most widely distributed software M&A research. Corum's M&A advisors are highly experienced former tech CEOs, who are supported by the industry's leading researchers, writers and valuators. Corum also does much to educate the industry with its conferences and webinars and the industry's most widely distributed software and IT M&A research.

About OrthoView
OrthoView Holdings Ltd develops and offers pre-operative planning solutions that are used in more than 60 countries worldwide by an estimated 11,000 orthopaedic surgeons. The OrthoView solution provides an easy to use method of planning and templating with digital x-ray images, incorporating specialist on-screen measuring tools and patented wizards. The OrthoView digital prosthesis template library provides a comprehensive range of digital templates, developed in partnership with over 60 orthopaedic implant manufacturers. OrthoView offers pre-operative planning and templating for joint replacement surgery and fracture management, as well as specialist tools for paediatric assessment, limb deformity correction and spinal measurements. For more information, visit

About Materialise
With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Materialise has been playing an active role in the field of AM since 1990, through its involvement in AM for industrial and medical applications, by providing biomedical and clinical solutions such as medical image processing and surgical simulations and by developing unique solutions for its customers' prototyping, production, and medical needs. For additional information, please visit:

Image Available:
Image Available:

Contact Information:

Timothy Goddard